1. Home
  2. AUPH vs NSP Comparison

AUPH vs NSP Comparison

Compare AUPH & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • NSP
  • Stock Information
  • Founded
  • AUPH 1993
  • NSP 1986
  • Country
  • AUPH Canada
  • NSP United States
  • Employees
  • AUPH N/A
  • NSP N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • NSP Professional Services
  • Sector
  • AUPH Health Care
  • NSP Consumer Discretionary
  • Exchange
  • AUPH Nasdaq
  • NSP Nasdaq
  • Market Cap
  • AUPH 1.6B
  • NSP 1.7B
  • IPO Year
  • AUPH 1999
  • NSP 1997
  • Fundamental
  • Price
  • AUPH $16.44
  • NSP $35.30
  • Analyst Decision
  • AUPH Strong Buy
  • NSP Hold
  • Analyst Count
  • AUPH 3
  • NSP 3
  • Target Price
  • AUPH $17.67
  • NSP $47.67
  • AVG Volume (30 Days)
  • AUPH 2.2M
  • NSP 1.1M
  • Earning Date
  • AUPH 11-04-2025
  • NSP 11-03-2025
  • Dividend Yield
  • AUPH N/A
  • NSP 6.79%
  • EPS Growth
  • AUPH N/A
  • NSP N/A
  • EPS
  • AUPH 0.55
  • NSP 0.45
  • Revenue
  • AUPH $265,808,000.00
  • NSP $6,757,000,000.00
  • Revenue This Year
  • AUPH $17.33
  • NSP $5.06
  • Revenue Next Year
  • AUPH $14.31
  • NSP $5.35
  • P/E Ratio
  • AUPH $29.89
  • NSP $79.02
  • Revenue Growth
  • AUPH 20.62
  • NSP 3.19
  • 52 Week Low
  • AUPH $6.55
  • NSP $31.00
  • 52 Week High
  • AUPH $16.47
  • NSP $95.98
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 75.78
  • NSP 40.88
  • Support Level
  • AUPH $14.94
  • NSP $31.00
  • Resistance Level
  • AUPH $15.81
  • NSP $34.55
  • Average True Range (ATR)
  • AUPH 0.61
  • NSP 1.40
  • MACD
  • AUPH 0.06
  • NSP 0.66
  • Stochastic Oscillator
  • AUPH 97.97
  • NSP 86.38

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

Share on Social Networks: